Drug Shortage Report for ACT LOVASTATIN

Last updated on 2019-03-14 History
Report ID 65513
Drug Identification Number 02248573
Brand name ACT LOVASTATIN
Common or Proper name LOVASTATIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LOVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-03-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-03-14 French Compare
v3 2019-03-14 English Compare
v2 2018-10-23 French Compare
v1 2018-10-23 English Compare